| Lipoprotein (a) reduction with proprotein convertase subtilisin/kexin type 9 inhibitors: a systematic review and meta-analysis I Farmakis, I Doundoulakis, A Pagiantza, S Zafeiropoulos, C Antza, ... Journal of Cardiovascular Pharmacology 77 (3), 397-407, 2021 | 33 | 2021 |
| Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis L Hobohm, IT Farmakis, K Keller, B Scibior, AC Mavromanoli, ... Clinical Research in Cardiology 112 (10), 1351-1361, 2023 | 29 | 2023 |
| COVID-19 infection and its impact on case fatality in patients with pulmonary embolism L Hobohm, I Sagoschen, S Barco, IT Farmakis, U Fedeli, S Koelmel, ... European Respiratory Journal 61 (1), 2023 | 27 | 2023 |
| Effects of major antihypertensive drug classes on erectile function: a network meta-analysis IT Farmakis, N Pyrgidis, I Doundoulakis, I Mykoniatis, E Akrivos, ... Cardiovascular Drugs and Therapy 36 (5), 903-914, 2022 | 23 | 2022 |
| Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area D Voci, U Fedeli, IT Farmakis, L Hobohm, K Keller, L Valerio, E Schievano, ... Thrombosis research 212, 44-50, 2022 | 21 | 2022 |
| Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week S Zafeiropoulos, I Doundoulakis, IT Farmakis, S Miyara, D Giannis, ... Journal of the American College of Cardiology 79 (7), 682-694, 2022 | 20 | 2022 |
| Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism IT Farmakis, L Valerio, S Barco, E Alsheimer, R Ewert, G Giannakoulas, ... European Respiratory Journal 61 (6), 2023 | 14 | 2023 |
| Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry IT Farmakis, S Barco, AC Mavromanoli, G Agnelli, AT Cohen, ... Journal of the American Heart Association 11 (20), e027514, 2022 | 14 | 2022 |
| Echocardiography in pulmonary arterial hypertension: is it time to reconsider its prognostic utility? IT Farmakis, E Demerouti, P Karyofyllis, G Karatasakis, M Stratinaki, ... Journal of Clinical Medicine 10 (13), 2826, 2021 | 14 | 2021 |
| Risk for recurrent cardiovascular events and expected risk reduction with optimal treatment 1 year after an acute coronary syndrome S Zafeiropoulos, I Farmakis, A Kartas, A Arvanitaki, A Pagiantza, ... The American Journal of Cardiology 133, 7-14, 2020 | 13 | 2020 |
| Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design A Boulmpou, A Kartas, I Farmakis, S Zafeiropoulos, V Nevras, ... Hellenic Journal of Cardiology 60 (4), 249-253, 2019 | 13 | 2019 |
| Comparison of the 2017 American Academy of Pediatrics with the fourth report and the 2016 European Society of Hypertension guidelines for the diagnosis of hypertension and the … I Goulas, I Farmakis, I Doundoulakis, C Antza, K Kollios, M Economou, ... Journal of Hypertension 40 (2), 197-204, 2022 | 10 | 2022 |
| Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial S Zafeiropoulos, I Farmakis, A Kartas, A Arvanitaki, A Pagiantza, ... Atherosclerosis 323, 37-43, 2021 | 10 | 2021 |
| Performance status and long-term outcomes in cancer-associated pulmonary embolism: insights from the Hokusai-VTE cancer study IT Farmakis, S Barco, AC Mavromanoli, SV Konstantinides, L Valerio Cardio Oncology 4 (4), 507-518, 2022 | 9 | 2022 |
| Atrial high-rate episodes in patients with devices without a history of atrial fibrillation: a systematic review and meta-analysis I Doundoulakis, M Gavriilaki, D Tsiachris, P Arsenos, CK Antoniou, ... Cardiovascular Drugs and Therapy 36 (5), 951-958, 2022 | 9 | 2022 |
| Pulmonary Embolism and Pregnancy—Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients L Hobohm, IT Farmakis, T Münzel, S Konstantinides, K Keller Frontiers in Cardiovascular Medicine 9, 856594, 2022 | 9 | 2022 |
| Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary … IT Farmakis, P Karyofyllis, F Frantzeskaki, E Demerouti, A Anthi, ... Hellenic Journal of Cardiology 64, 93, 2022 | 9 | 2022 |
| Annual mortality related to pulmonary embolism in the US before and during the COVID-19 pandemic IT Farmakis, L Valerio, B Bikdeli, JM Connors, G Giannakoulas, ... Journal of the American College of Cardiology 80 (16), 1579-1581, 2022 | 8 | 2022 |
| Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis I Milioglou, I Farmakis, M Neudeker, Z Hussain, A Guha, G Giannakoulas, ... Journal of Thrombosis and Thrombolysis 52, 1137-1150, 2021 | 8 | 2021 |
| Cardiotoxicity of azithromycin in COVID-19: an overall proportion meta-analysis I Farmakis, I Minopoulou, G Giannakoulas, A Boutou Advances in Respiratory Medicine 90 (3), 171-182, 2022 | 7 | 2022 |
George GiannakoulasAristotle University of ThessalonikiVerified email at auth.gr
